Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.

Piotr Adamowicz, Joanna Gieroń, Dominika Gil, Wojciech Lechowicz, Agnieszka Skulska, Bogdan Tokarczyk

Drug Testing and Analysis January 1, 2016 DOI: 10.1002/dta.1924 (opens in new tab) via PubMed

Summary

AI-generated from the abstract

New psychoactive substances (NPS) appeared in 112 of 1,058 analyzed forensic cases from 2012–2014, with 75 cases in 2014 alone. The overall prevalence of NPS (15.1–17.6%) was similar to that of amphetamine alone (15.1–16.5%). Cathinones made up 88% of the NPS detected, most frequently 3-MMC, α-PVP, and pentedrone. In 35% of cases, a single NPS was the only drug found; two or more NPS appeared in 19% of cases; and most cases (65%) involved NPS alongside conventional drugs such as amphetamines, cannabinoids, cocaine, or benzodiazepines. NPS were often found in drivers' blood, posing a challenge for toxicologists due to limited data on their effects on psychomotor performance.

Study at a glance

Characteristics Observational cohort Peer reviewed
Sample size 1,058
Population Forensic cases where biological material was analyzed for new psychoactive substances
Duration Three-year period 2012-2014
Keywords Blood Designer drugs Legal highs New psychoactive substances Drug prevalence
Citations 87
Key finding New psychoactive substances were detected in 10.6% of analyzed forensic cases from 2012–2014, with cathinones accounting for 88% of NPS identifications.

Abstract

New psychoactive substances (NPS) pose a challenge for forensic and clinical toxicologists, as well as for legislators. We present our findings from cases where NPS have been detected in biological material. During the three-year period 2012-2014 we found NPS in 112 cases (out of 1058 analyzed), with 75 cases in 2014 alone. The prevalence of all NPS (15.1-17.6%) was similar to amphetamine alone that was detected in 15.1-16.5% of cases. The new drugs found belonged to the following classes: cathinones (88%), synthetic cannabinoids (5%), phenethylamines (3%), piperazines and piperidines (3%), arylalkylamines (1%) and other (1%). The drugs detected were (in the order of decreased frequency): 3-MMC (50), α-pyrrolidinopentiophenone (α-PVP) (23), pentedrone (16), 3',4'-methylenedioxy-α-pyrrolidinobutyrophenone (MDPBP) (12), synthetic cannabinoid UR-144 (7), ethcathinone (5), mephedrone (5), methylenedioxypyrovalerone (MDPV) (4), 4-methylethcathinone (4-MEC) (3), buphedrone (3), desoxypipradrol (2-DPMP) (3), methylone (2) and 2C-B (2). In single cases, 2-methylmethcathinone (2-MMC), 2C-P, eutylone, 25I-NBOMe, meta-chlorophenylpiperazine (mCPP), ephedrone, methiopropamine (MPA), and 5-(2-aminopropyl)benzofuran (5-APB) were found. One NPS was the sole agent in 35% of all cases, and two or more NPS were present in 19% of cases. NPS (one or more) with other conventional drugs (like amphetamines, cannabinoids, cocaine, and benzodiazepines) were detected in most (65%) of the cases. NPS were very often detected in the blood of drivers which was a challenge for toxicologists due to a lack of data on their influence on psychomotor performance. A review of concentrations showed a wide range of values in different types of cases, especially driving under the influence of drugs (DUID) and intoxication.

Comments

No comments yet.

Log in to comment